Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06265220
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-02-09
Brief Title:
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
Sponsor:
Artiva Biotherapeutics Inc
Organization:
Artiva Biotherapeutics Inc
Organization Data
Organization:
Artiva Biotherapeutics Inc
Class:
INDUSTRY
Study ID:
AB-101-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Artiva Biotherapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None